BIOCAD
BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological manufacturing facilities, as well as preclinical and clinical research infrastructure compliant with international standards.
BIOCAD
Industry:
Biotechnology Health Care Manufacturing Web Development
Founded:
2001-01-01
Address:
Saint Petersburg, Saint Petersburg City, Russian Federation
Country:
Russian Federation
Website Url:
http://www.biocadglobal.com
Total Employee:
1001+
Status:
Active
Contact:
+78123804933
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Domain Not Resolving Nginx
Similar Organizations
BioVectra
BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients.
Clinical Reports Sweden AB
Clinical Reports is a manufacturing company with solid medical clinic, research, and drug testing expertise and knowledge.
Fujifilm Diosynth Biotechnologies
Fujifilm Diosynth Biotechn, contract development & manufacturing provider for preclinical, clinical and commercial biologics manufacturing.
Tide Microfluidics
Tide Microfluidics manufactures monodisperse microbubbles and microdroplets.
Current Employees Featured
Founder
Official Site Inspections
http://www.biocadglobal.com Semrush global rank: 6.91 M Semrush visits lastest month: 698
- Host name: 178.170.176.70
- IP address: 178.170.176.70
- Location: Russia
- Latitude: 55.7386
- Longitude: 37.6068
- Timezone: Europe/Moscow
More informations about "BioCAD"
BioCAD - Crunchbase Company Profile & Funding
BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological …See details»
BIOCAD — международная инновационная …
Биотехнологическая компания biocad — ведущая в России инновационная компания, объединившая ...See details»
BIOCAD - LinkedIn
BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological …See details»
BIOCAD - Products, Competitors, Financials, Employees, …
Biocadglobal.com. Overview & Products; People; About BIOCAD. BIOCAD is a biotechnology company focused on drug development and manufacturing within the pharmaceutical and …See details»
BIOCAD Information - RocketReach
BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological …See details»
BIOCAD - European Pharmaceutical Review
BIOCAD is one of the largest innovative biotech companies in Russia. The company combines world-class R&D centers and modern pharmaceutical and biotechnological production with …See details»
Leading innovative biologic and small-molecule therapeutic
BIOCAD, the leading Russian biotechnology company, owns a robust portfolio of globally marketed products and is focusing its efforts on research and development of novel …See details»
Biocad Company Profile - Office Locations, Competitors, Revenue …
Biocad is a biotechnology company engaged in full-cycle drug development and manufacturing. Its medicines are dedicated to treating complex health conditions, such as cancer, HIV and …See details»
Leading innovative biologic and small- molecule therapeutic
Www.biocadglobal.com BIOCAD. The leading Russian biotechnology company delivers advanced therapeutics in oncology, autoimmune disease and hematology. Irina Kenyukhova, PR …See details»
Biocad - VentureRadar
Website: https://biocadglobal.com/ Provides full-cycle drug development and manufacturing, with a focus on treatments for cancer, HIV, Hepatitis C, and multiple ...See details»
BIOCAD | LinkedIn
BIOCAD | 13,050 followers on LinkedIn. Science for life! | BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development …See details»
CJSC BIOCAD - CMOCRO
BIOCAD is Russia\\'s leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological …See details»
BIOCAD Overview, Competitors, News, and Employees | Clodura.AI
BIOCAD is Russias leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological …See details»
Article: Evolving into an international biotech market driver
Jan 14, 2022 As in 2021 BIOCAD has more than 200 marketing authorizations in 30 countries and develops new products using its own platform, it is hard to believe that at the beginning of …See details»
BIOCAD has become an industrial partner of Vector in the
Jun 15, 2019 The biotechnology company BIOCAD has signed an agreement with the State Scientific Center for Virology and Biotechnology «Vektor» (Novosibirsk) on joint work on a …See details»
BIOCAD | LinkedIn
BIOCAD | 12.526 seguidores no LinkedIn. Science for life! | BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development …See details»
BIOCAD — innovative biotechnology company - biocadglobal.com
We have determined the crystal structure of the Fab fragment of netakimab at 1.9 Å resolution. High variability in the orientation of light and heavy chains of the Fab fragment of netakimab …See details»
BIOCAD — innovative biotechnology company - biocadglobal.com
PD-1/PD-L1-based therapy has been named a revolution in cancer treatment. By the end of 2018, more than 100 anti-PD-1 and anti-PD-L1 antibodies were in various stages of development, …See details»
BIOCAD — innovative biotechnology company - biocadglobal.com
At the present time, gene technologies play a key part in the development of new approaches to the diagnostics and therapy of diseases. Russian scientists have already successfully …See details»
BIOCAD — innovative biotechnology company - biocadglobal.com
Randomized double-blind clinical trial comparing safety and efcacy of the biosimilar BCD-021 with reference bevacizumab. Daniil L. Stroyakovskiy , Natalya V. Fadeeva , Marina P. Matrosova , …See details»